Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 70 of the 71 references it cites were found in a registry or an index.

Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediates

Open access

Abstract

The neuroactive mycotoxin lolitrem B causes a neurological syndrome in grazing livestock resulting in hyperexcitability, muscle tremors, ataxia and, in severe cases, clonic seizures and death. To define the effects of the major toxin lolitrem B in the brain, a functional metabolomic study was undertaken in which motor coordination and tremor were quantified and metabolomic profiling undertaken to determine relative abundance of both toxin and key neurotransmitters in various brain regions in male mice. Marked differences were observed in the duration of tremor and coordination between lolitrem B pathway members, with some showing protracted effects and others none at all. Lolitrem B was identified in liver, kidney, cerebral cortex and thalamus but not in brainstem or cerebellum which were hypothesised previously to be the primary site of action. Metabolomic profiling showed significant variation in specific neurotransmitter and amino acid profiles over time. This study demonstrates accumulation of lolitrem B in the brain, with non-detectable levels of toxin in the brainstem and cerebellum, inducing alterations in metabolites such as tyrosine, suggesting a dynamic catecholaminergic response over time. Temporal characterisation of key pathways in the pathophysiological response of lolitrem B in the brain were also identified.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-019-45170-7

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 A biosynthetic map of lolitrem B sourced from KEGG pathways68–70 highlighting selected compounds tested for tremorgenic and motor deficit activity.
Figure 1 A biosynthetic map of lolitrem B sourced from KEGG pathways68–70 highlighting selected compounds tested for tremorgenic and motor deficit activity.CC BY · PubMed Central
Figure 2 Lolitrem B intoxicated mice exhibit a dose-dependent tremor (a1) and latency to falling (a2) over 24 h time. Significant tremor and impaired motor coordination was measured for LolBLOW (n = 8) and LolBHIGH (n = 6) compared to ControlVEH (n = 7). Terpendole C intoxicated mice monitored show a dose-dependent tremor (b1) and latency to falling (b2) over 2 h. Significant tremor and impaired motor coordination was measured for TerpCLOW (n = 8) and TerpCHIGH (n = 8) compared to ControlVEH (n = 7). No significant tremor or motor impairment was found in the Control (n = 8) animals. All data are mean ± S.E.M. P values determined by two-way ANOVA by uncorrected Fisher’s LSD post-test for multigroup comparison against vehicle control. High dose: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; low dose: #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.
Figure 2 Lolitrem B intoxicated mice exhibit a dose-dependent tremor (a1) and latency to falling (a2) over 24 h time. Significant tremor and impaired motor coordination was measured for LolBLOW (n = 8) and LolBHIGH (n = 6) compared to ControlVEH (n = 7). Terpendole C intoxicated mice monitored show a dose-dependent tremor (b1) and latency to falling (b2) over 2 h. Significant tremor and impaired motor coordination was measured for TerpCLOW (n = 8) and TerpCHIGH (n = 8) compared to ControlVEH (n = 7). No significant tremor or motor impairment was found in the Control (n = 8) animals. All data are mean ± S.E.M. P values determined by two-way ANOVA by uncorrected Fisher’s LSD post-test for multigroup comparison against vehicle control. High dose: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001; low dose: #p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001.CC BY · PubMed Central
Figure 3 Terpendole B and terpendole E intoxicated mice exhibit no tremor (a1,b1) and latency to falling (a2,b2) over time. No significant tremor or alteration in motor coordination was observed between TerpELOW (n = 8), TerpEHIGH (triangle, n = 8) and TerpB (n = 8) compared to ControlVEH (n = 7). No significant tremor or motor impairment was found in Control (n = 8) mice. All data are mean ± S.E.M.
Figure 3 Terpendole B and terpendole E intoxicated mice exhibit no tremor (a1,b1) and latency to falling (a2,b2) over time. No significant tremor or alteration in motor coordination was observed between TerpELOW (n = 8), TerpEHIGH (triangle, n = 8) and TerpB (n = 8) compared to ControlVEH (n = 7). No significant tremor or motor impairment was found in Control (n = 8) mice. All data are mean ± S.E.M.CC BY · PubMed Central
Figure 4 Lolitrem B intoxicated mice exhibit tremor at 6 h and 24 h post treatment. A dose-dependent response is observed for LolBLOW (n = 8) and LolBHIGH (n = 7). The profile here is similar to that observed previously (Fig. 2). No significant tremor was identified in the vehicle control (n = 8) and control (n = 8) mice. All data are mean ± S.E.M. Significance was analysed by two-way ANOVA by uncorrected Fisher’s LSD post-test for multigroup comparison against vehicle control, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Figure 4 Lolitrem B intoxicated mice exhibit tremor at 6 h and 24 h post treatment. A dose-dependent response is observed for LolBLOW (n = 8) and LolBHIGH (n = 7). The profile here is similar to that observed previously (Fig. 2). No significant tremor was identified in the vehicle control (n = 8) and control (n = 8) mice. All data are mean ± S.E.M. Significance was analysed by two-way ANOVA by uncorrected Fisher’s LSD post-test for multigroup comparison against vehicle control, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Figure 5 Lolitrem B concentrations in lipophilic extracts of tissues harvested at 6 h and 24 h post treatment (a) showing lolitrem B accumulation over time, in the cerebral cortex: LolBHIGH [(6 h, n = 6), (24 h, n = 8)] and LolBLOW [(6 h, n = 3), (24 h, n = 4)] as well as the thalamus: LolBHIGH [(6 h, n = 7), (24 h, n = 6)] and LolBLOW [(6 h, n = 3), (24 h, n = 7)]. Lolitrem B was below the detection limit in the cerebellum and brainstem regions. Graph (b) shows elimination of lolitrem B over time from the kidney: LolBHIGH [(6 h, n = 7), (24 h, n = 8)] and LolBLOW [(6 h, n = 7), (24 h, n = 8)], as well as from the liver: LolBHIGH [(6 h, n = 7), (24 h, n = 8)] and LolBLOW [(6 h, n = 8), (24 h, n = 8)]. All data are mean ± S.E.M.
Figure 5 Lolitrem B concentrations in lipophilic extracts of tissues harvested at 6 h and 24 h post treatment (a) showing lolitrem B accumulation over time, in the cerebral cortex: LolBHIGH [(6 h, n = 6), (24 h, n = 8)] and LolBLOW [(6 h, n = 3), (24 h, n = 4)] as well as the thalamus: LolBHIGH [(6 h, n = 7), (24 h, n = 6)] and LolBLOW [(6 h, n = 3), (24 h, n = 7)]. Lolitrem B was below the detection limit in the cerebellum and brainstem regions. Graph (b) shows elimination of lolitrem B over time from the kidney: LolBHIGH [(6 h, n = 7), (24 h, n = 8)] and LolBLOW [(6 h, n = 7), (24 h, n = 8)], as well as from the liver: LolBHIGH [(6 h, n = 7), (24 h, n = 8)] and LolBLOW [(6 h, n = 8), (24 h, n = 8)]. All data are mean ± S.E.M.CC BY · PubMed Central
Figure 6 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBHIGH 6 h (n = 7) vs ControlVEH 6 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [3.0%, 97.0%] (b) thalamus [9.7%, 90.3%] (c) cerebellum [6.3%, 93.8%] (d) brainstem [5.4%, 94.6%] tissues.
Figure 6 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBHIGH 6 h (n = 7) vs ControlVEH 6 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [3.0%, 97.0%] (b) thalamus [9.7%, 90.3%] (c) cerebellum [6.3%, 93.8%] (d) brainstem [5.4%, 94.6%] tissues.CC BY · PubMed Central
Figure 7 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBHIGH 6 h (n = 7) vs LolBHIGH 24 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [9.1%, 90.3%] (b) thalamus [4.3%, 95.7%] (c) cerebellum [9.0%, 90.9%] (d) brainstem [5.8%, 94.3%] tissues.
Figure 7 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBHIGH 6 h (n = 7) vs LolBHIGH 24 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [9.1%, 90.3%] (b) thalamus [4.3%, 95.7%] (c) cerebellum [9.0%, 90.9%] (d) brainstem [5.8%, 94.3%] tissues.CC BY · PubMed Central
Figure 8 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBLOW 6 h (n = 7) vs ControlVEH 6 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [9.9%, 90.2%] (b) thalamus [9.1%, 90.9%] (c) cerebellum [9.6%, 90.3%] (d) brainstem [10.4%, 89.6%] tissues.
Figure 8 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBLOW 6 h (n = 7) vs ControlVEH 6 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [9.9%, 90.2%] (b) thalamus [9.1%, 90.9%] (c) cerebellum [9.6%, 90.3%] (d) brainstem [10.4%, 89.6%] tissues.CC BY · PubMed Central
Figure 9 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBLOW 6 h (n = 7) vs LolBLOW 24 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [11.5%, 88.5%] (b) thalamus [15.4%, 84.6%] (c) cerebellum [9.0%, 90.9%] (d) brainstem [7.1%, 92.9%] tissues.
Figure 9 PCA and loadings plot of ESI + LCMS amino acid quantitation data acquired from aqueous extracts of individual brain tissue samples showing LolBLOW 6 h (n = 7) vs LolBLOW 24 h (n = 7). Conformation of the samples to the PCA model is shown as: [Q residuals, Hotelling T2]. These include (a) cerebral cortex [11.5%, 88.5%] (b) thalamus [15.4%, 84.6%] (c) cerebellum [9.0%, 90.9%] (d) brainstem [7.1%, 92.9%] tissues.CC BY · PubMed Central
Figure 10 ROC curve of top 4 features (Table 2) showing AUC = 0.95 and a sensitivity and specificity at a 95% confidence interval of 0.86–0.99.
Figure 10 ROC curve of top 4 features (Table 2) showing AUC = 0.95 and a sensitivity and specificity at a 95% confidence interval of 0.86–0.99.CC BY · PubMed Central
Figure 11 A schematic of the metabolic response to lolitrem B intoxication in the brain. Shown here are commonly affected pathways. The blue arrows represent the direction (increase/decrease in abundance) of metabolites in the cerebral cortex of LolBHIGH 6 h. BBB refers to blood-brain barrier and AAA refers to aromatic amino acids. BCAA refers to branched chain amino acids.
Figure 11 A schematic of the metabolic response to lolitrem B intoxication in the brain. Shown here are commonly affected pathways. The blue arrows represent the direction (increase/decrease in abundance) of metabolites in the cerebral cortex of LolBHIGH 6 h. BBB refers to blood-brain barrier and AAA refers to aromatic amino acids. BCAA refers to branched chain amino acids.CC BY · PubMed Central
Figure 12 The power output spectra of (a) LolBHIGH and (b) LolBLOW mice exhibiting tremors compared to (c) Control and (d) ControlVEH mice. The tremor was defined by the AUC of tremor frequency bandwidth divided by AUC of overall motion power [100* (10–30 Hz power)/(0–45 Hz power)]. This ratio is expressed as motion power percentage (MPP) and in untreated mice; the MPP is approximately 40 to 55%, corresponding not to any visible tremor but to normal motion within these bandwidths.
Figure 12 The power output spectra of (a) LolBHIGH and (b) LolBLOW mice exhibiting tremors compared to (c) Control and (d) ControlVEH mice. The tremor was defined by the AUC of tremor frequency bandwidth divided by AUC of overall motion power [100* (10–30 Hz power)/(0–45 Hz power)]. This ratio is expressed as motion power percentage (MPP) and in untreated mice; the MPP is approximately 40 to 55%, corresponding not to any visible tremor but to normal motion within these bandwidths.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

See all 16

Metadata

Authors
Reddy, P., Rochfort, S., Read, E., Deseo, M., Jaehne, E., Van Den Buuse, M., Guthridge, K., Combs, M., Spangenberg, G., & Quinn, J.
Affiliations
  • La Trobe University (AU)
  • Agriculture Victoria (AU)
  • Charles Sturt University (AU)
Corresponding author
Rochfort, Simone
Venue
Scientific Reports
Published
2019-06-27
Volume
9
Issue
1
Pages
9364-9364
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2954244067
Cited by
16
References
71
Citations by year
2025: 2 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3
FWCI
2.03
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Charles Sturt University Research Output (CRO) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • La Trobe University
  • Agriculture Victoria
Topics
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Mycotoxins in Agriculture and Food
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Plant and fungal interactions
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
lolitrem B, tremorgenic mycotoxins, neurotoxicity, tremor, motor coordination, brain metabolomics, neurotransmitters, amino acids, tyrosine, biosynthetic intermediates
MeSH terms
Animals, Brain, Disease Models, Animal, Dose-Response Relationship, Drug, Mycotoxins, Organ Specificity, ROC Curve, Tremor, Indole Alkaloids, Mice, Biosynthetic Pathways, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediates. https://app.cochat.ai/papers/10.1038/s41598-019-45170-7
The paper
Reddy, P., Rochfort, S., Read, E., Deseo, M., Jaehne, E., Van Den Buuse, M., Guthridge, K., Combs, M., Spangenberg, G., & Quinn, J. (2019). Tremorgenic effects and functional metabolomics analysis of lolitrem B and its biosynthetic intermediates. Scientific Reports. https://doi.org/10.1038/s41598-019-45170-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.